JEFFERSON CITY, Mo (KMIZ) The Jefferson City Walk to End Alzheimer’s raised over $65,000 as of Sunday. 264 people showed up to the walk showing support for the Alzheimer’s Association, carrying purple, blue, yellow and orange flowers to show their connection to the disease. Walk to End Alzheimer’s Committee member Haley Johannpeter said she finds
Continue Reading
COLUMBIA, Mo. (KMIZ) This month President Joe Biden signed two pieces of bipartisan legislation into law which aim to aid the fight against Alzheimer’s Disease. According to the Alzheimer’s Association nearly 7 million people across the U.S. are battling the disease and this number is only expected to grow. NAPA Reauthorization Act The NAPA Reauthorization
Continue Reading
COLUMBIA, Mo. (KMIZ) According to the latest data from the Alzheimer’s Association, more than 122,000 Missourians 65 years and older are battling Alzheimer’s Disease. Across the country, nearly 7 million people are living with the disease. Almost two-thirds of those affected are women. “The mission of the Alzheimer’s Association is to raise funds and awareness
Continue Reading
COLUMBIA, Mo. (KMIZ) The Jefferson City Walk to End Alzheimer’s raised over $104,000 Sunday. The Alzheimer’s Association’s mission is to end Alzheimer’s and all other dementia through research and maximizing support. According to the organization, 55 million people live with Alzheimer’s and other dementias worldwide. Alzheimer’s is the most common form of dementia among adults,
Continue Reading
Jefferson City resident Joey O’Connor lost his mother Betty Jean O’Connor on March 11. She had been diagnosed with Alzheimer’s disease two years ago.
Continue Reading
The Alzheimer’s Impact Movement works with lawmakers to advance and develop policies to help with the research, care and support of people with Alzheimer’s.
Continue Reading
Some researchers in Columbia studying Alzheimer’s disease are using artificial intelligence to help identify the “most important factors.”
Continue Reading JEFFERSON CITY, Mo. (KMIZ) More than 120,000 Missouri residents are living with Alzheimer’s, and that number is expected to grow by more than 8% in the next two years, according to the Alzheimer’s Association. Missouri’s elected officials are recognizing this epidemic, and one of the ways they’ve taken action is with the state’s Alzheimer’s State
Continue Reading
This week, ABC 17 News is continuing our ‘Living with Alzheimer’s’ coverage leading up to the Jefferson City Walk to End Alzheimer’s on Sunday.
Continue Reading
COLUMBIA, Mo. (KMIZ) Hundreds of Columbia residents showed their support today and raised over $210,000 dollars for the fight against alzheimer’s. More than 6 million Americans are living with Alzheimer’s. About 2,600 residents in Boone County are living with the disease, along with 1,400 in Cole County and 300 in Osage County. Data released at the recent
Continue Reading
ABC 17 News Anchor Meghan Drakas is sharing her family’s experience with Alzheimer’s disease in the leadup to Columbia’s Walk to End Alzheimer’s on Saturday.
Continue Reading
More than 120,000 people living in Missouri have Alzheimer’s.
Continue Reading
Last year, the Columbia Walk to End Alzheimer’s raised $195,594. This year, the walk has a goal of raising $220,000.
Continue Reading
Alzheimer’s affects locals from all walks of life.
Continue ReadingBy MARI YAMAGUCHI Associated Press TOKYO (AP) — Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies. It’s the first drug for the treatment of the disease in a country with a rapidly aging population. Leqembi was developed by Japanese drugmaker Eisai and
Continue Reading
Ahead of the Columbia Walk to End Alzheimer’s on Saturday, ABC 17 News is digging into Alzheimer’s Disease and the resources available to families.
Continue Reading
By LAURAN NEERGAARD AP Medical Writer WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday. Eli Lilly and Co. is seeking Food and Drug Administration approval of donanemab. If cleared, it would be only the second Alzheimer’s treatment convincingly shown to
Continue Reading
By Jacqueline Howard, CNN The US National Institute on Aging is moving forward with efforts to build a real-world Alzheimer’s disease database as part of its aim to improve, support and conduct more dementia research. Last month, the agency, part of the National Institutes of Health, posted a notice of the grant for the six-year
Continue Reading
By Sandee LaMotte, CNN Alzheimer’s disease strikes women harder than men — over two-thirds of those who descend into dementia’s devastating twilight are female at birth. That’s likely due to biological reasons that remain poorly understood, according to the Alzheimer’s Association. One key piece of the enigma: Women lose sexual hormones such as estrogen when
Continue Reading
By Sandee LaMotte, CNN The eyes are more than a window to the soul — they’re also a reflection of a person’s cognitive health. “The eye is the window into the brain,” said ophthalmologist Dr. Christine Greer, director of medical education at the Institute for Neurodegenerative Diseases in Boca Raton, Florida. “You can see directly
Continue Reading